South Texas Accelerated Research Therapeutics (START) is a leading organization in advanced cancer research, with locations across the United States and Europe. Specializing in phase I clinical trials, START is dedicated to developing novel anti-cancer agents to provide patients worldwide with more effective treatment options.
With a team of dedicated doctors and researchers, START conducts both clinical and nonclinical research to discover new candidates for potential anti-cancer compounds. Their global leadership in phase I cancer research and commitment to developing new cancer treatments make them a pivotal player in the fight against cancer.
Generated from the website